Results 121 to 130 of about 8,396 (186)

Amino Compound-Synthesized Gold Nanoparticles for SARS-CoV-2 Antigen Delivery. [PDF]

open access: yesPharmaceutics
Rego LS   +7 more
europepmc   +1 more source

The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. [PDF]

open access: yesActa Derm Venereol
Wang S   +9 more
europepmc   +1 more source

Long-term outcomes in nephropathic cystinosis: a review. [PDF]

open access: yesPediatr Nephrol
Chang HE   +5 more
europepmc   +1 more source

Synthesis of carbon quantum dots based on hemp leaves and cysteamine for latent fingerprint detection and their potential therapeutic anticancer application. [PDF]

open access: yesNanoscale Adv
Kampangta R   +10 more
europepmc   +1 more source

Optimizing Low Crude Protein Diets with Coated Cysteamine Hydrochloride and Exogenous Alkaline Protease Supplementation in Broiler Chickens. [PDF]

open access: yesVet Sci
Siddique HAB   +8 more
europepmc   +1 more source

Development of cysteamine loaded liposomes in liquid and dried forms for improvement of cysteamine stability

open access: yesInternational Journal of Pharmaceutics, 2020
Despite the high aqueous solubility of cysteamine, its unpleasant organoleptic properties, hygroscopicity, instability in solutions, and poor pharmacokinetic profile are the main drawbacks that limit its use for medical and cosmetic purposes. In this study, cysteamine-loaded liposomes were prepared using the ethanol injection method.
Hélène Greige, Catherine Charcosset
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Cysteamine and cystamine

1987
Publisher Summary This chapter discusses about cysteamine and cystamine. Cysteamine (2-aminoethanethiol) is formed in mammalian tissues by the enzymatic hydrolysis of pantetheine, and has the role in the biosynthesis of hypotaurine. Cysteamine has been used therapeutically to treat cystinosis and sickle cell anemia, and has been used as a protective ...
M W, Duffel, D J, Logan, D M, Ziegler
openaire   +2 more sources

Home - About - Disclaimer - Privacy